1-3 of 3
Bassam Mattar, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Treatment with the Chimeric Antigen Receptor (CAR) T Cell Therapy Lisocabtagene Maraleucel (liso-cel) in the Nonuniversity Setting: Initial Results from the Outreach Study

John E. Godwin, MD, Cesar O. Freytes, MD, Michael Maris, MD, Don A. Stevens, MD, Daanish Hoda, MD, Bassam Mattar, MD, Juan C. Varela, MDPhD, Mohamad Cherry, MDMS, James Essell, MD, Jay Courtright, MD, Suzanne R. Fanning, DO, Habte A. Yimer, MD, Nikolaus S. Trede, MD PhD, Marina Youssef, PharmD, James Lymp, PhD, Carlos Bachier, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 50–52.
https://doi.org/10.1182/blood-2020-136640
Published: 2020
Journal Articles

Phase 1, Open-Label, Randomized, Bioequivalence Study of 2 Bendamustine Hydrochloride Formulations; A Ready-to-Dilute Low-Volume, Rapid Infusion Solution and a Lyophilized Powder Formulation

W Jeffrey Edenfield, MD, Bassam Mattar, MD, Stephen P Anthony, DO, Peter Mutch, Brian Chanas, Mark Smith
Journal: Blood
Blood (2015) 126 (23): 4857.
https://doi.org/10.1182/blood.V126.23.4857.4857
Published: 2015
Journal Articles

Comparative Safety of Two Bendamustine Hydrochloride Formulations; A Ready-to-Dilute Low-Volume, Rapid Infusion Solution, and a Lyophilized Powder: Results from a Phase 1 Study

Bassam Mattar, MD, Stephen P Anthony, DO, W Jeffrey Edenfield, MD, Mark Smith, Adrian Hepner
Journal: Blood
Blood (2015) 126 (23): 4861.
https://doi.org/10.1182/blood.V126.23.4861.4861
Published: 2015